Perritt Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2
Closed -$1.53K 200
2025
Q3
$1.53K Hold
2
﹤0.01% 295
2025
Q2
$1.56K Hold
2
﹤0.01% 310
2025
Q1
$1.65K Hold
2
﹤0.01% 318
2024
Q4
$1.54K Buy
+2
New +$1.66K ﹤0.01% 287
2024
Q2
Sell
-7
Closed -$5.46K 331
2024
Q1
$5.46K Hold
7
﹤0.01% 281
2023
Q4
$4.09K Hold
7
﹤0.01% 282
2023
Q3
$3.76K Buy
+7
New +$3.61K ﹤0.01% 280

Other funds holding LLY

Perritt Capital Management's LLY Position: Q4 2025 in Review

Perritt Capital Management sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 2 shares — an estimated $1.53K sold.

Perritt Capital Management first reported a position in LLY in Q3 2023 and held it in 7 quarters. The position peaked at $5.46K in Q1 2024. 4,431 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Perritt Capital Management reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • Perritt Capital Management sold 2 Eli Lilly shares in Q4 2025, an estimated $1.53K.
  • Perritt Capital Management first reported a position in Eli Lilly in Q3 2023 and held it in 7 quarters.
  • Perritt Capital Management's Eli Lilly position peaked at $5.46K in Q1 2024.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Perritt Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.